tirzepatide fda shortage update Trade association opposes decision to remove weight-loss drugs from list FDA says this weight loss

Both authors declare that they have no conflicts of interest

The alpaca project (immunizations and blood sampling) has been approved by the animal welfare authority LAVES with the reference numbers 33.9-42502-05-13A351, 33.9-42502-05-17A220 and 33.19-42502-04-22-00210

Discontinuation rates in SURMOUNT-1 were 14% to 16% across dose groups, meaning most people tolerate the medication well enough to continue treatment

"Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis"